Under current securities laws, members of an IPO underwriting syndicate are prohibited from publishing equity research before and up to the IPOpricing date and for a period of 40 days after the pricing of an IPO.
Carlyle is putting less emphasis on pricing shares high at the IPO, instead hoping they rise in value once they are traded, according to people familiar with the matter.
Just 3.4% of all U.S.-listed IPO deals since 1995 have increased both the number of shares and the price range of their IPOs before pricing, according to Dealogic.